ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

FARN Faron Pharmaceuticals Oy

145.00
5.00 (3.57%)
30 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Faron Pharmaceuticals Oy LSE:FARN London Ordinary Share FI4000153309 ORD NPV (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  5.00 3.57% 145.00 140.00 160.00 155.00 140.00 140.00 21,598 16:35:01
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -28.73M -0.4177 -3.59 103.18M

Faron Pharmaceuticals Oy Notification of Major Interest in Shares (0225M)

07/10/2016 1:41pm

UK Regulatory


TIDMFARN

RNS Number : 0225M

Faron Pharmaceuticals Oy

07 October 2016

 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
-------------------------------------------------------------------------------------------------------- 
 
 1. Identity of the issuer or                                          Faron Pharmaceuticals Oy 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
-----------------------------------------------------------  ------------------------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
-------------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights 
--------------------------------------------------------------------------------------------------  ---- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
--------------------------------------------------------------------------------------------------  ---- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
--------------------------------------------------------------------------------------------------  ---- 
 An event changing the breakdown of voting rights 
--------------------------------------------------------------------------------------------------  ---- 
 Other (please                                            Disclosure as per Company's Articles       Yes 
  specify):                                               of Association 
-------------------------------------------------------  -----------------------------------------  ---- 
 3. Full name of person(s)                                                     City Financial Investment 
  subject to the                                                              Company Limited, acting as 
  notification obligation:                                             Investment Manager and Authorised 
  (iii)                                                                        Corporate Director of the 
                                                                          City Financial Absolute Equity 
                                                                                                    Fund 
---------------------------------------------------------  --------------------------------------------- 
 4. Full name of shareholder(s)                             BNY Mellon Trust and Depositary 
  (if different from 3.):(iv)                                as Trustee to the City Financial 
                                                             Absolute Equity Fund 
---------------------------------------------------------  --------------------------------------------- 
 5. Date of the transaction                                                                    21.9.2016 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
---------------------------------------------------------  --------------------------------------------- 
 6. Date on which issuer                                    4.10.2016 
  notified: 
---------------------------------------------------------  --------------------------------------------- 
 7. Threshold(s) that is/are                                Above 3%, 3.80% 
  crossed or 
  reached: (vi, vii) 
---------------------------------------------------------  --------------------------------------------- 
 
 
 
 8. Notified details: 
---------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
---------------------------------------------------------------------------------------------------------------------- 
 Class/type      Situation                         Resulting situation after the triggering 
  of              previous                          transaction 
  shares          to the triggering 
                  transaction 
  if possible 
  using 
  the ISIN 
  CODE 
--------------  --------------------------------  -------------------------------------------------------------------- 
                 Number           Number           Number         Number of voting            % of voting 
                 of               of                of shares      rights                      rights (x) 
                 Shares           Voting 
                                  Rights 
--------------  ---------------  ---------------  -------------  --------------------------  ------------------------- 
                                                   Direct         Direct        Indirect      Direct        Indirect 
                                                                   (xi)          (xii) 
--------------      -----------      -----------  -------------  ------------  ------------  ------------  ----------- 
 
 Ordinary 
 Shares 
 FI40000153309   zero             zero             1,000,000      1,000,000     zero          3.80%         zero 
--------------  ---------------  ---------------  -------------  ------------  ------------  ------------  ----------- 
 
 B: Qualifying Financial Instruments 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of financial   Expiration       Exercise/                     Number of voting              % of voting 
  instrument          date             Conversion                    rights that                   rights 
                      (xiii)           Period (xiv)                  may be 
                                                                     acquired if 
                                                                     the 
                                                                     instrument 
                                                                     is 
                                                                     exercised/ 
                                                                     converted. 
------------------  ---------------  ----------------------------  ----------------------------  --------------------- 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of           Exercise         Expiration       Exercise/    Number of voting              % of voting 
 financial          price            date            Conversion    rights instrument             rights (xix, 
 instrument                          (xvii)          period        refers to                     xx) 
                                                     (xviii) 
----------------  ---------------  ---------------  -----------  ----------------------------  ----------------------- 
                                                                                                Nominal       Delta 
----------------  ---------------  ---------------  -----------  ----------------------------  ------------  --------- 
 
 
 Total (A+B+C) 
---------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                                          Percentage of voting rights 
---------------------------------------------------------------  ----------------------------------------------------- 
 1,000,000                                                        3.80% 
---------------------------------------------------------------  ----------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
---------------------------------------------------------------------------------------------------- 
 
   The voting rights are managed and controlled by City 
   Financial Investment Company Limited, Investment manager 
   and ACD to the City Financial Absolute Equity Fund. 
 
 Proxy Voting: 
---------------------------------------------------------------------------------------------------- 
 10. Name of the proxy holder: 
-------------------------------------------------------------  ------------------------------------- 
 11. Number of voting rights proxy 
  holder will cease 
  to hold: 
-------------------------------------------------------------  ------------------------------------- 
 12. Date on which proxy holder will 
  cease to hold 
  voting rights: 
-------------------------------------------------------------  ------------------------------------- 
 
 
  13. Additional information:                                           Notification using the total 
                                                                  voting rights figure of 26,311,704 
-------------------------------------------------------------  ------------------------------------- 
 14. Contact name:                                              Chris Sturdee 
-------------------------------------------------------------  ------------------------------------- 
 15. Contact telephone number:                                  +44 (0)20 7726 9869 
-------------------------------------------------------------  ------------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLBDBDGGSGBGLR

(END) Dow Jones Newswires

October 07, 2016 08:41 ET (12:41 GMT)

1 Year Faron Pharmaceuticals Oy Chart

1 Year Faron Pharmaceuticals Oy Chart

1 Month Faron Pharmaceuticals Oy Chart

1 Month Faron Pharmaceuticals Oy Chart

Your Recent History

Delayed Upgrade Clock